4707 |
How to Manage Complication TAVR Case |
Alan C. Yeung |
Apr. 28. 18 |
4706 |
TAVR Experience with Edwards SAPIEN 3 in Korea |
Cheol Woong Yu |
Apr. 28. 18 |
4705 |
Less Invasive Left Ventricular Enhancement(LIVE-Revivent) for Treatment of Advanced Heart Failure: Technique and GLOBAL Data |
Teguh Santoso |
Apr. 28. 18 |
4704 |
Electrical Neuromodulation and Renal Denervation for Heart Failure |
Wojciech Wojakowski |
Apr. 28. 18 |
4703 |
Very Long-term Outcomes After LAA Closure |
Maurice Buchbinder |
Apr. 28. 18 |
4702 |
PREVENT Trial: Update and Interesting Cases |
Seung-Jung Park |
Apr. 28. 18 |
4701 |
Dynamic Changes of Non-culprit Lesion over Time Under Standard of Care Therapy |
Evelyn Regar |
Apr. 28. 18 |
4700 |
Coronary Physiology Perspective |
Bon-Kwon Koo |
Apr. 28. 18 |
4699 |
Coronary Imaging Perspective |
Akiko Maehara |
Apr. 28. 18 |
4698 |
Pathologic Perspective |
Renu Virmani |
Apr. 28. 18 |